Both von Willebrand factor antigen (vWF:Ag) and von Willebrand factor ristocetin cofactor activities (vWF:RCo) were significantly higher in COVID-19 patients independently from their platelet count on admission compared to healthy subjects (p < 0.001) (data not shown). This evidence concerns the gene RENBP and COVID-19.